CellectCell, Inc. Announces Georgia Research Alliance Phase IIB Funding for the Commercialization of Novel Label-Free Cell Isolation Technology

Atlanta, GA, August 12, 2016 --(PR.com)-- CellectCell, Inc., a company that develops novel cell isolation and purification technology, announced today the completion of milestones related to its Phase IIA grant and receipt of Phase IIB grant funding from the Georgia Research Alliance (GRA).

CellectCell’s initial focus is the commercialization of a disposable cell isolation cassette for stem cell research. The CellectCell MicroCassette™ is used to rapidly isolate many different adherent cell types, including mesenchymal stem cells, induced pluripotent stem cells (iPSCs), neural cells, cardiac cells, fibroblasts and cancer cells. Using the MicroCassette, cells of interest are isolated with high purity and high cell survival. This technology, exclusively licensed to CellectCell, Inc. by the Georgia Tech Research Corporation, is based on research at the Georgia Institute of Technology which showed that cells have distinct adhesive signatures that can be exploited to efficiently and reproducibly isolate iPSCs from parental colonies, from partially reprogrammed cells, and from differentiated progeny.

“We are pleased to continue our collaboration with GRA as we work toward commercialization of this simple and robust, label-free cell sorting system,” stated Rebecca Marshall, President and CEO of CellectCell. “We believe this new tool has the potential to revolutionize the efficiency and precision of stem cell isolation for researchers world-wide. Now that we have successfully completed prototype development and testing, we are ready to advance rapidly through manufacturing transfer toward commercial launch of this breakthrough technology.”

The GRA Ventures Program has launched 170 new companies and created nearly 1,500 jobs. GRA’s portfolio of companies has attracted more than $1 billion in equity investment to date.

“We congratulate CellectCell on meeting their recent milestones,” said H. Lee Herron, VP, Venture Development, Georgia Research Alliance. “They are continuing to make significant progress on their technology and we are encouraged by the great strides the team is making.”

About CellectCell, Inc.:
CellectCell, Inc. is a development-stage company focused on providing novel stem cell isolation and purification tools for life science research. CellectCell is dedicated to developing and commercializing unique technologies to improve the ease and specificity of cell separation for cell researchers, cell manufacturers and biotechnology companies. Visit CellectCell.com for more information.

About the Georgia Research Alliance:
The Georgia Research Alliance (GRA) works to expand research and commercialization capacity in Georgia’s universities to recruit world-class talent, seed new companies and transform lives. For over twenty-five years, GRA has worked to strengthen the university research enterprise in Georgia by working in partnership with the University System of Georgia and the Georgia Department of Economic Development to create the companies and jobs of Georgia’s future. Visit www.gra.org for more information.

Any questions or comments can be directed to Rebecca Marshall, President & CEO, CellectCell, Inc. at rebecca@cellectcell.com.